Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines

Weight management recommendations for youth with Down syndrome: Expert recommendations

An expert consensus on the recommendations for the use of biomarkers in Fabry disease

The treatment of obesity in children and adolescents: consensus position statement of the Italian society of pediatric endocrinology and diabetol...

Asia-Pacific Consensus Recommendations on X-Linked Hypophosphatemia: Diagnosis, Multidisciplinary Management, and Transition From Pediatric to Adult Care

Guidelines for physical activity in children with heart disease

Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development

Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2)

Executive Summary: International Clinical Practice Guidelines for Pediatric Ventilator Liberation, A Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network Document

International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood

Evaluation and Management of Deficiency of Adenosine Deaminase 2 An International Consensus Statement

Polish recommendations for diagnosis and therapy of paediatric stroke

Australian guidelines for the management of children with achondroplasia

The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder

Australian and New Zealand consensus guideline for paediatric newly diagnosed immune thrombocytopaenia endorsed by Australian New Zealand Children’s Haematology and Oncology Group

Use of non-sugar sweeteners WHO guideline

［摘要］风湿免疫疾病的诊疗手段日新月异，不断涌现的新型免疫抑制剂为免 疫性疾病的临床治疗开创了新格局。同时，该领域药品说明书更新滞后于临床 实践发展的现象日益突出，超药品说明书用药（...

［摘要］随着现今肿瘤发病率和死亡率的持续上升，抗肿瘤药物的研发已成为 全球创新药研发的热点问题，药物研发投入高速增长，新药上市速度明显提高， 使肿瘤的规范诊疗、合理用药，尤其是新型的...

【摘要】 黏多糖贮积症Ⅰ型是1种由于编码α‑L‑艾杜糖苷酶的基因变异所致的罕见常染色体隐 性遗传病。本病可累及多系统、多器官，临床表现差异较大，病程呈进行性进展，早期诊断、早...

【摘要】 非选择性 β受体阻滞剂普萘洛尔作为用于婴幼儿血管瘤治疗的一线药物具有较好的疗 效，但其可能存在气道高反应性、低血糖以及中枢神经系统潜在影响的药物不良反应。近年来，选择性 β１...